Paper · 39669205
Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway.
Liu S and 6 others. Front Pharmacol, 2024. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway. Papers, record 39669205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39669205
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,780,421 | Antihypertensive drugs. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28780421 | PubMed |
| 2 | 36,274,411 | Kaempferol inhibits renal fibrosis by suppression of the sonic hedgehog signaling pathway. | Phytomedicine | 2023 | https://conductscience.org/library/papers/36274411 | PubMed |
| 3 | 27,322,403 | The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. | Curr Protoc Bioinformatics | 2016 | https://conductscience.org/library/papers/27322403 | PubMed |
| 4 | 15,571,058 | Chronic kidney disease: prevention and treatment of common complications. | Am Fam Physician | 2004 | https://conductscience.org/library/papers/15571058 | PubMed |
| 5 | 34,175,443 | Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/34175443 | PubMed |
| 6 | 23,877,587 | Nephrology in china. | Nat Rev Nephrol | 2013 | https://conductscience.org/library/papers/23877587 | PubMed |
| 7 | 16,581,343 | Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. | J Lab Clin Med | 2006 | https://conductscience.org/library/papers/16581343 | PubMed |
| 8 | 15,608,251 | Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15608251 | PubMed |
| 9 | 27,578,176 | Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. | Development | 2016 | https://conductscience.org/library/papers/27578176 | PubMed |
| 10 | 22,543,366 | DAVID-WS: a stateful web service to facilitate gene/protein list analysis. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22543366 | PubMed |
1 to 10 of 55
See all 55 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41,585,231 | Baricitinib in chronic kidney disease: an exploratory analysis integrating network toxicology, molecular docking and pharmacovigilance. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41585231 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39669205
GET https://conductscience.org/api/papers/v1/39669205/references?page=2